Doses in sensitive organs during prostate treatment with a 60Co unit

Area of Science:

• Medical Physics
• Radiation Oncology
• Dosimetry

Background:

• Prostate cancer radiotherapy aims to deliver high doses to the tumor while minimizing radiation exposure to surrounding organs.
• Accurate dosimetry is crucial for assessing treatment efficacy and predicting potential long-term side effects, including secondary malignancies.
• Thermoluminescent dosimeters (TLDs) are commonly used for measuring absorbed radiation doses in clinical and research settings.

Purpose of the Study:

• To quantify the absorbed radiation dose in the bladder, rectum, and thyroid during prostate radiotherapy.
• To estimate the effective dose and the probability of secondary malignancies in these organs following treatment.
• To evaluate the dosimetric accuracy of a (60)Co unit for prostate cancer treatment.

Main Methods:

• A water phantom simulating human anatomy was used to position thermoluminescent dosimeters (TLDs) at the locations of the prostate, bladder, rectum, and thyroid.
• A total dose of 200 cGy was delivered to the prostate using a (60)Co unit with irradiations at four angles (0, 90, 180, 270 degrees).
• TLD readings were analyzed to determine the absorbed dose in each critical organ.

Main Results:

• The absorbed doses in the bladder, rectum, and thyroid were successfully measured using TLDs.
• Calculations based on these absorbed doses provided estimates for effective doses to these organs.
• The study enabled an estimation of the probability of developing secondary malignancies in the thyroid, rectum, and bladder.

Conclusions:

• Thermoluminescent dosimetry is a viable method for assessing organ doses during prostate radiotherapy.
• The measured doses provide a basis for understanding the risk of secondary cancers associated with this treatment modality.
• Further research can refine these estimates and inform treatment planning to further reduce risks.